Long-term outcome of cardiac resynchronization therapy patients in the elderly

[1]  C. Israel,et al.  2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy. , 2021, European heart journal.

[2]  A. Rapacciuolo,et al.  Does the Age Affect the Outcomes of Cardiac Resynchronization Therapy in Elderly Patients? , 2021, Journal of clinical medicine.

[3]  B. Merkely,et al.  Sex-Specific Patterns of Mortality Predictors Among Patients Undergoing Cardiac Resynchronization Therapy: A Machine Learning Approach , 2021, Frontiers in Cardiovascular Medicine.

[4]  Zengzhang Liu,et al.  The benefits of defibrillator in heart failure patients with cardiac resynchronization therapy: A meta‐analysis , 2020, Pacing and clinical electrophysiology : PACE.

[5]  B. Merkely,et al.  Lateral left ventricular lead position is superior to posterior position in long‐term outcome of patients who underwent cardiac resynchronization therapy , 2020, ESC heart failure.

[6]  G. Filippatos,et al.  Effect of Empagliflozin on the Clinical Stability of Patients With Heart Failure and a Reduced Ejection Fraction , 2020, Circulation.

[7]  S. Saito,et al.  Impact of age on mid-term clinical outcomes and left ventricular reverse remodeling after cardiac resynchronization therapy. , 2020, Journal of cardiology.

[8]  S. Solomon,et al.  Estimating lifetime benefits of comprehensive disease-modifying pharmacological therapies in patients with heart failure with reduced ejection fraction: a comparative analysis of three randomised controlled trials , 2020, The Lancet.

[9]  Akshay S. Desai,et al.  Effect of Dapagliflozin on Worsening Heart Failure and Cardiovascular Death in Patients With Heart Failure With and Without Diabetes. , 2020, JAMA.

[10]  Juan Lin,et al.  Utility of the Modified Frailty Index to Predict Cardiac Resynchronization Therapy Outcomes and Response. , 2020, The American journal of cardiology.

[11]  R. Mourilhe-Rocha,et al.  Clinical outcomes and mortality in old and very old patients undergoing cardiac resynchronization therapy , 2019, PloS one.

[12]  M. Domingo,et al.  Trends in modes of death in heart failure over the last two decades: less sudden death but cancer deaths on the rise , 2019, European journal of heart failure.

[13]  B. Hiebert,et al.  Clinical outcomes of cardiac resynchronization therapy with and without a defibrillator in elderly patients with heart failure , 2018, Journal of arrhythmia.

[14]  R. Młynarski,et al.  Frailty as a predictor of negative outcomes after cardiac resynchronization therapy , 2017, Pacing and clinical electrophysiology : PACE.

[15]  T. Huynh,et al.  Implantable cardioverter-defibrillator use in elderly patients receiving cardiac resynchronization: A meta-analysis. , 2017, Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese.

[16]  A. Brandes,et al.  Age and Outcomes of Primary Prevention Implantable Cardioverter-Defibrillators in Patients With Nonischemic Systolic Heart Failure , 2017, Circulation.

[17]  M. Rivero‐Ayerza,et al.  Incremental benefit of cardiac resynchronisation therapy with versus without a defibrillator , 2017, Heart.

[18]  I. Goldenberg,et al.  Morbidity and mortality with cardiac resynchronization therapy with pacing vs. with defibrillation in octogenarian patients in a real-world setting , 2016, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[19]  F. Alghamdi,et al.  Management of heart failure in the elderly , 2017, Current opinion in cardiology.

[20]  P. Ponikowski,et al.  [2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure]. , 2016, Kardiologia polska.

[21]  M. A. Arias,et al.  Primary prevention implantable cardioverter-defibrillator and cardiac resynchronization therapy-defibrillator in elderly patients: results of a Spanish multicentre study. , 2016, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[22]  S. Saba,et al.  Clinical Characteristics and Outcomes of Older Cardiac Resynchronization Therapy Recipients Using a Pacemaker versus a Defibrillator , 2016, Journal of cardiovascular electrophysiology.

[23]  S. Saba,et al.  Clinical outcomes in cardiac resynchronization therapy-defibrillator recipients 80 years of age and older. , 2016, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[24]  A. Moss,et al.  Cardiac Resynchronization in Different Age Groups: A MADIT-CRT Long-Term Follow-Up Substudy. , 2016, Journal of cardiac failure.

[25]  M. Walsh,et al.  Heart Failure in Non-Caucasians, Women, and Older Adults: A White Paper on Special Populations From the Heart Failure Society of America Guideline Committee. , 2015, Journal of cardiac failure.

[26]  Jeroen J. Bax,et al.  Left Ventricular Reverse Remodeling, Device-Related Adverse Events, and Long-Term Outcome After Cardiac Resynchronization Therapy in the Elderly , 2014, Circulation. Cardiovascular quality and outcomes.

[27]  Lluís Mont,et al.  2013 ESC guidelines on cardiac pacing and cardiac resynchronization therapy: the task force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA). , 2013, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[28]  H. Wiste,et al.  Outcomes of Cardiac Resynchronization Therapy in the Elderly , 2013, Pacing and clinical electrophysiology : PACE.

[29]  A. Capucci,et al.  Cardiac resynchronization therapy improves ejection fraction and cardiac remodelling regardless of patients' age. , 2013, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[30]  P. Vandervoort,et al.  Response to cardiac resynchronization therapy in elderly patients (≥70 years) and octogenarians , 2013, European journal of heart failure.

[31]  T. McDonagh,et al.  The impact of age on clinical outcomes following cardiac resynchronisation therapy , 2013, Journal of Interventional Cardiac Electrophysiology.

[32]  B. Seifert,et al.  Comparison of benefit and mortality of implantable cardioverter-defibrillator therapy in patients aged ≥75 years versus those <75 years. , 2012, The American journal of cardiology.

[33]  F. Rutten,et al.  Primary care patients with heart failure in the last year of their life. , 2012, Family practice.

[34]  S. Solomon,et al.  Improved Outcome with Preventive Cardiac Resynchronization Therapy in the Elderly: A MADIT‐CRT Substudy , 2011, Journal of cardiovascular electrophysiology.

[35]  G. Boriani,et al.  Comparison of the usefulness of cardiac resynchronization therapy in three age-groups (<65, 65-74 and ≥75 Years) (from the InSync/InSync ICD Italian Registry). , 2011, The American journal of cardiology.

[36]  D. Levy,et al.  A Systematic Assessment of Causes of Death After Heart Failure Onset in the Community: Impact of Age at Death, Time Period, and Left Ventricular Systolic Dysfunction , 2011, Circulation. Heart failure.

[37]  Finn Gustafsson,et al.  2010 Focused Update of ESC Guidelines on Device Therapy in Heart Failure , 2011 .

[38]  M. Gold,et al.  Prevention of disease progression by cardiac resynchronization therapy in patients with asymptomatic or mildly symptomatic left ventricular dysfunction: insights from the European cohort of the REVERSE (Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction) trial. , 2009, Journal of the American College of Cardiology.

[39]  R. Teixeira,et al.  Cardiac resynchronization therapy is effective even in elderly patients with comorbidities , 2009, Journal of Interventional Cardiac Electrophysiology.

[40]  Jordana Kron,et al.  Benefit of cardiac resynchronization in elderly patients: results from the Multicenter InSync Randomized Clinical Evaluation (MIRACLE) and Multicenter InSync ICD Randomized Clinical Evaluation (MIRACLE-ICD) trials , 2009, Journal of Interventional Cardiac Electrophysiology.

[41]  Stefano Ghio,et al.  Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms. , 2008, Journal of the American College of Cardiology.

[42]  David O. Martin,et al.  Mortality of Heart Failure Patients After Cardiac Resynchronization Therapy: Identification of Predictors , 2008, Journal of cardiovascular electrophysiology.

[43]  M. Frenneaux,et al.  Long-term effects of cardiac resynchronization therapy in octogenarians: a comparative study with a younger population. , 2008, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[44]  S. Saba,et al.  Elevated Serum Creatinine at Baseline Predicts Poor Outcome in Patients Receiving Cardiac Resynchronization Therapy , 2008, Pacing and clinical electrophysiology : PACE.

[45]  Jagmeet P. Singh,et al.  The Impact of Age and Gender on Cardiac Resynchronization Therapy Outcome , 2007, Pacing and clinical electrophysiology : PACE.

[46]  W. Grimm,et al.  Outcomes of Elderly Recipients of Implantable Cardioverter Defibrillators , 2007, Pacing and clinical electrophysiology : PACE.

[47]  Nick Freemantle,et al.  Longer-term effects of cardiac resynchronization therapy on mortality in heart failure [the CArdiac REsynchronization-Heart Failure (CARE-HF) trial extension phase]. , 2006, European heart journal.

[48]  Jeroen J. Bax,et al.  Comparison of effectiveness of cardiac resynchronization therapy in patients <70 versus > or =70 years of age. , 2005, The American journal of cardiology.

[49]  S. Connolly,et al.  Diminishing proportional risk of sudden death with advancing age: implications for prevention of sudden death. , 2004, American heart journal.

[50]  Albert W Wu,et al.  Noncardiac comorbidity increases preventable hospitalizations and mortality among Medicare beneficiaries with chronic heart failure. , 2003, Journal of the American College of Cardiology.

[51]  M. Cesari,et al.  The effects of cognitive impairment on mortality among hospitalized patients with heart failure. , 2003, The American journal of medicine.

[52]  Paul W Armstrong,et al.  Anemia Is Common in Heart Failure and Is Associated With Poor Outcomes: Insights From a Cohort of 12 065 Patients With New-Onset Heart Failure , 2003, Circulation.

[53]  Harlan M Krumholz,et al.  Representation of the elderly, women, and minorities in heart failure clinical trials. , 2002, Archives of internal medicine.

[54]  Thomas Lavergne,et al.  Long-term benefits of biventricular pacing in congestive heart failure: results from the MUltisite STimulation in cardiomyopathy (MUSTIC) study. , 2002, Journal of the American College of Cardiology.

[55]  C. Jurkovitz,et al.  Anemia and renal insufficiency are independent risk factors for death among patients with congestive heart failure admitted to community hospitals: a population-based study. , 2002, Journal of the American Society of Nephrology : JASN.

[56]  H. Krumholz,et al.  Correlates and impact on outcomes of worsening renal function in patients > or =65 years of age with heart failure. , 2000, The American journal of cardiology.